Junaidin Junaidin, Abdurachman Abdurachman, Sudiana I Ketut
Department of Nursing, Amanah School of Health Sciences, Indonesia.
Department of Anatomy, Histology, and Pharmacology, Faculty of Medicine, Airlangga University, Indonesia.
Pediatr Endocrinol Diabetes Metab. 2025;31(2):59-67. doi: 10.5114/pedm.2025.152596.
Meliponine honey, derived from stingless bees, has significant therapeutic potential due to its bioactive compounds, such as polyphenols and flavonoids, which contribute to its antioxidant and antidiabetic properties. However, the variations in honey quality based on bee species and geographical origin still require further exploration to maximize its benefits. This study aimed to evaluate the variations in antioxidant and antidiabetic properties of meliponine honey based on stingless bee species and their geographical origins.
This scoping review follows the Joanna Briggs Institute methodology, including a comprehensive literature search in major scientific databases such as PubMed, Scopus, DOAJ, Wiley Online, and Google Scholar. Data from relevant studies were extracted and analyzed using a thematic synthesis approach to identify patterns in the bioactivity of Trigona honey.
A total of 23 articles met the inclusion criteria. The analysis revealed that the antioxidant properties of meliponine honey are influenced by phenolic and flavonoid content, which vary according to geographical origin, local flora, and bee species. The antidiabetic activity of the honey is associated with its ability to inhibit a-amylase and a-glucosidase enzymes and enhance insulin release. Honey from regions such as Kalimantan and Sarawak exhibited higher bioactive content compared to other areas.
Meliponine honey is a promising natural therapeutic agent for diabetes management, with its bioactive quality influenced by bee species, geographical origin, and botanical sources. This study supports further development to optimize the benefits of meliponine honey through holistic approaches and broader clinical trials.
源自无刺蜂的麦卢卡蜂蜜因其生物活性化合物,如多酚和黄酮类化合物,具有显著的治疗潜力,这些化合物赋予了其抗氧化和抗糖尿病特性。然而,基于蜜蜂种类和地理来源的蜂蜜质量差异仍需进一步探索,以最大限度地发挥其益处。本研究旨在评估基于无刺蜂种类及其地理来源的麦卢卡蜂蜜抗氧化和抗糖尿病特性的差异。
本综述遵循乔安娜·布里格斯研究所的方法,包括在主要科学数据库如PubMed、Scopus、DOAJ、Wiley Online和谷歌学术上进行全面的文献检索。使用主题综合方法提取和分析相关研究的数据,以确定Trigona蜂蜜生物活性的模式。
共有23篇文章符合纳入标准。分析表明,麦卢卡蜂蜜的抗氧化特性受酚类和黄酮类含量的影响,这些含量因地理来源、当地植物群和蜜蜂种类而异。蜂蜜的抗糖尿病活性与其抑制α-淀粉酶和α-葡萄糖苷酶以及增强胰岛素释放的能力有关。与其他地区相比,加里曼丹和砂拉越等地区的蜂蜜具有更高的生物活性成分。
麦卢卡蜂蜜是一种有前途的用于糖尿病管理的天然治疗剂,其生物活性质量受蜜蜂种类、地理来源和植物来源的影响。本研究支持通过整体方法和更广泛的临床试验进一步开发,以优化麦卢卡蜂蜜的益处。